Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Net Income (2016 - 2025)

Historic Net Income for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $1.3 million.

  • Xtant Medical Holdings' Net Income rose 12603.5% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 10995.57%. This contributed to the annual value of -$16.4 million for FY2024, which is 259227.27% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Net Income of $1.3 million as of Q3 2025, which was up 12603.5% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Net Income ranged from a high of $9.2 million in Q3 2023 and a low of -$5.0 million during Q3 2024
  • For the 5-year period, Xtant Medical Holdings' Net Income averaged around -$1.3 million, with its median value being -$2.2 million (2023).
  • As far as peak fluctuations go, Xtant Medical Holdings' Net Income plummeted by 753103.45% in 2022, and later soared by 49230.77% in 2023.
  • Xtant Medical Holdings' Net Income (Quarter) stood at -$2.4 million in 2021, then grew by 7.07% to -$2.2 million in 2022, then plummeted by 94.79% to -$4.3 million in 2023, then increased by 26.45% to -$3.2 million in 2024, then soared by 141.33% to $1.3 million in 2025.
  • Its Net Income was $1.3 million in Q3 2025, compared to $3.6 million in Q2 2025 and $58000.0 in Q1 2025.